Biomea Fusion, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Biomea Fusion, Inc. (BMEA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 5.16 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-08-05
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 5.16M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.54M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.13M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.46M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2026-06-30 | 5.16M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 4.54M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 4.13M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 4.46M shares 10-Q · filed 2025-11-04 |
| 2025-06-30 | 4.42M shares 10-Q · filed 2025-08-05 |
| 2025-03-31 | 5.80M shares 10-Q · filed 2025-05-05 |
| 2024-12-31 | 5.48M shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 4.98M shares 10-Q · filed 2024-10-29 |
| 2024-06-30 | 4.52M shares 10-Q · filed 2024-07-31 |
| 2024-03-31 | 4.02M shares 10-Q · filed 2024-05-02 |
| 2023-12-31 | 3.47M shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 3.04M shares 10-Q · filed 2023-10-30 |
| 2023-06-30 | 2.62M shares 10-Q · filed 2023-07-31 |
| 2023-03-31 | 2.12M shares 10-Q · filed 2023-05-02 |
| 2022-12-31 | 1.75M shares 10-K · filed 2023-03-28 |
| 2022-09-30 | 1.44M shares 10-Q · filed 2022-11-07 |
| 2022-06-30 | 1.19M shares 10-Q · filed 2022-08-01 |
| 2022-03-31 | 906.93K shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 636.36K shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 446.21K shares 10-Q · filed 2021-11-03 |
| 2021-03-31 | 125.69K shares 10-Q · filed 2021-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |